StockDriftsStockDriftsHLB Science (343090) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for HLB Science is dated 2024-02-09; the most recent is 2025-12-31. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | SELL | 합병 | YOON JONG SUN | CEO | -120.0K | ₩2,080 | +0.0% | ₩250M ($173K) |
| 2025-10-22 | SELL | 장외매도 | HLB바이오스텝 HLB Biostep | - | -559.0K | ₩1,724 | -20.6% | ₩964M ($669K) |
| 2025-10-21 | SELL | 장외매도 | HLB바이오스텝 HLB Biostep | - | -559.0K | ₩1,720 | -20.9% | ₩961M ($668K) |
| 2025-05-09 | BUY | 행사가액조정 | HLB바이오스텝 HLB Biostep | - | 189.4K | ₩1,579 | +31.7% | ₩299M ($208K) |
| 2025-02-09 | SELL | 행사가액조정 | HLB바이오스텝 HLB Biostep | - | -133.6K | ₩2,135 | +2.6% | ₩285M ($198K) |
| 2024-11-09 | BUY | 행사가액조정 | HLB바이오스텝 HLB Biostep | - | 161.6K | ₩1,855 | +12.1% | ₩300M ($208K) |
| 2024-10-11 | BUY | 제3자배정유상증자 | HLB생명과학 HLB Life Science | - | 1.4M | ₩1,980 | +5.0% | ₩2.8B ($1.9M) |
| 2024-08-09 | BUY | 행사가액조정 | HLB바이오스텝 HLB Biostep | - | 117.7K | ₩2,170 | -4.2% | ₩255M ($177K) |
| 2024-02-09 | SELL | 행사가액조정 | HLB바이오스텝 HLB Biostep | - | -335.2K | ₩2,600 | +20.0% | ₩871M ($605K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for HLB Science. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.